Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
A 5 mg vial of BPC-157 reconstituted with 2 mL of water yields 2.5 mg/mL, and a typical 250 mcg dose is only 10 units
If youre injecting tirzepatide from a vial, pinch an inch of skin and fatty tissue between your fingers
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
Continued progressive improvement
This guide walks through what the before and after timeline actually looks like at 3, 6, and 12 months, what determines the magnitude of your results, and who is the right candidate for this protocol
Research suggests that this peptide helps block the transformation of non-fatty foods into body fat, making it harder for the body to store new weight
